ReviewMedical oncology (Northwood, London, England)2022

PIM1/STAT3 axis: a potential co-targeted therapeutic approach in triple-negative breast cancer.

Sutapa Mahata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.